The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis
Open accessAbstract
Nonalcoholic steatohepatitis (NASH) may progress to liver fibrosis and cirrhosis. Mechanisms directly involved in the development of fibrosis have been poorly investigated. Because connective tissue growth factor (CTGF) is an intermediate key molecule involved in the pathogenesis of fibrosing chronic liver diseases and is potentially induced by hyperglycemia, the aims of this study were to (1) study the expression of CTGF in vivo both in human liver biopsy specimens of patients with NASH and in an experimental model of obesity and type II diabetes (Zucker rats); and (2) analyze the effects of hyperglycemia and insulin in vitro on hepatic stellate cells. In vivo, CTGF overexpression was observed in the liver tissue of all of the 16 patients with NASH. CTGF immunostaining was mild in 7 cases (44%) and moderate or strong in 9 cases (56%). Staining was mainly detected in the liver extracellular matrix in parallel with the amount of liver fibrosis. Liver from fa/fa rats also showed CTGF overexpression by comparison with Fa/fa rats both at the messenger RNA (mRNA) level (3-fold increase) and protein level. In vitro, both CTGF mRNA and protein were significantly increased when hepatic stellate cells were incubated with either glucose or insulin. A slight increase in type I procollagen mRNA level was also observed in hepatic stellate cells incubated with glucose. In conclusion, this study suggests that hyperglycemia and insulin are key-factors in the progression of fibrosis in patients with NASH through the up-regulation of CTGF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Bedossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,003
Self-citationAssociation of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Phenotypes of Mouse diabetes and Rat fatty Due to Mutations in the OB (Leptin) Receptor
Chua, S. C., Chung, W. K., Wu-Peng, X. S., Zhang, Y., Liu, S.-M., Tartaglia, L., & Leibel, R. L. (1996) · Science · doi:10.1126/science.271.5251.994 · Cited by 1,075
Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038
Liver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, E., Thibault, V., Theodorou, I., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 973
Bradham, D. M., Igarashi, A., Potter, R. L., & Grotendorst, G. R. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.6.1285 · Cited by 880
Frazier, K., Williams, S., Kothapalli, D., Klapper, H., & Grotendorst, G. R. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12363389 · Cited by 757
Igarashi, A., Okochi, H., Bradham, D. M., & Grotendorst, G. R. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.6.637 · Cited by 706
FATTY, A NEW MUTATION IN THE RAT
ZUCKER, L. M., & ZUCKER, T. F. (1961) · Journal of Heredity · doi:10.1093/oxfordjournals.jhered.a107093 · Cited by 602
Ziyadeh, F. N., Sharma, K., Ericksen, M., & Wolf, G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117004 · Cited by 597
Expression of connective tissue growth factor in human renal fibrosis
Ito, Y., Aten, J., Bende, R. J., Oemar, B. S., Rabelink, T. J., Weening, J. J., & Goldschmeding, R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00820.x · Cited by 562
Nonalcoholic steatohepatitis: A study of 49 patients
Lee, R. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90249-9 · Cited by 550
Grotendorst, G. R., Okochi, H., & Hayashi, N. (1996) · PubMed · Cited by 528
Alcohollike liver disease in nonalcoholics
Diehl, A. M., Goodman, Z., & Ishak, K. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90183-7 · Cited by 483
Igarashi, A., Nashiro, K., Kikuchi, K., Sato, S., Ihn, H., Fujimoto, M., Grotendorst, G. R., & Takehara, K. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12345771 · Cited by 438
Fatty liver hepatitis and cirrhosis in obese patients
Adler, M., & Schaffner, F. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90740-x · Cited by 399
RISER, B. L., DENICHILO, M., CORTES, P., BAKER, C., GRONDIN, J. M., YEE, J., & NARINS, R. G. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11125 · Cited by 388
Murphy, M., Godson, C., Cannon, S., Kato, S., Mackenzie, H. S., Martin, F., & Brady, H. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5830 · Cited by 385
Cope, K., Risby, T., & Diehl, A. M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19267 · Cited by 357
Expression of connective tissue growth factor in experimental rat and human liver fibrosis
Paradis, V., Dargere, D., Vidaud, M., de Gouville, A.-C., Huet, S., Martinez, V., Gauthier, J.-M., Ba, N., Sobesky, R., Ratziu, V., et al. (1999) · Hepatology · doi:10.1002/hep.510300425 · Cited by 324
Self-citationNonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
Younossi, Z. M., Gramlich, T., Liu, Y. C., Matteoni, C. A., Petrelli, M., Goldblum, J. R., Rybicki, L. A., & McCullough, A. J. (1998) · PubMed · Cited by 321
Expression of cyr61, a growth factor-inducible immediate-early gene.
O'Brien, T. P., Yang, G. P., Sanders, L., & Lau, L. F. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3569 · Cited by 310
Joliot, V, Martinerie, C., Dambrine, G., Plassiart, G., Brisac, M., Crochet, J., & Perbal, B. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.10 · Cited by 310
Human Connective Tissue Growth Factor Is Expressed in Advanced Atherosclerotic Lesions
Oemar, B. S., Werner, A., Garnier, J.-M., Do, D.-D., Godoy, N., Nauck, M., Ma¨rz, W., Rupp, J., Pech, M., & Lu¨scher, T. F. (1997) · Circulation · doi:10.1161/01.cir.95.4.831 · Cited by 296
The synthesis of proteoglycans in fat-storing cells of rat liver
Schäfer, S., Zerbe, O., & Gressner, A. M. (1987) · Hepatology · doi:10.1002/hep.1840070411 · Cited by 255
Kireeva, M. L., Latinkić, B. V., Kolesnikova, T. V., Chen, C.-C., Yang, G. P., Abler, A. S., & Lau, L. F. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3548 · Cited by 237
Ryseck, R.-P., Macdonald-Bravo, H., Mattéi, M., & Bravo, R. (1991) · PubMed · Cited by 199
Soma, Y., & Grotendorst, G. R. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041400209 · Cited by 152
High Glucose Stimulates Proliferation and Collagen Type I Synthesis in Renal Cortical Fibroblasts
Han, D. C., Isono, M., Hoffman, B. B., & Ziyadeh, F. N. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1091891 · Cited by 147
Williams, E. J., Gaça, M., Brigstock, D. R., Arthur, M. J. P., & Benyon, R. C. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80244-5 · Cited by 141
Hong, H., Uzel, M. I., Duan, C., Sheff, M., & Trackman, P. C. (1999) · PubMed · Cited by 132
Connective tissue growth factor in human liver cirrhosis
Abou-Shady, M. A., Friess, H., Zimmermann, A., di Mola, F. F., Guo, X., Baer, H. U., & Büchler, M. W. (2000) · Liver International · doi:10.1034/j.1600-0676.2000.020004296.x · Cited by 103
Hepatic Free Fatty Acids in Alcoholic Liver Disease and Morbid Obesity
Mavrelis, P. G., Ammon, H. V., Gleysteen, J. J., KOMOROWSKI, R. A., & Charaf, U. K. (1983) · Hepatology · doi:10.1002/hep.1840030215 · Cited by 99
Nonalcoholic steatohepatitis: An expanded clinical entity
Farahvash, M. J. (1993) · Hepatology · doi:10.1016/0270-9139(93)92222-l · Cited by 89
High glucose increases growth and collagen synthesis in cultured human tubulointerstitial cells
Jones, S. C., Saunders, H. J., & Pollock, C. A. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00174.x · Cited by 69
Cited by
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Metadata
- Authors
- Paradis, V., Perlemuter, G., Bonvoust, F., Dargere, D., Parfait, B., Vidaud, M., Conti, M., Huet, S., Ba, N., Buffet, C., & Bedossa, P.
- Venue
- Hepatology
- Published
- 2001-10
- Volume
- 34
- Issue
- 4
- Pages
- 738-744
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2127375111
- Cited by
- 542
- References
- 40
- FWCI
- 14.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.